XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Ordinary shares
Class A
Ordinary shares
Class B
Treasury Stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Class A
Class B
Total
Beginning balance at Dec. 31, 2019 $ 28,800 $ 2,462 $ (1,063,547) $ 194,971,827 $ (153,598,346) $ (1,432,833)     $ 38,908,363
Beginning balance (in shares) at Dec. 31, 2019 2,880,056,332 246,224,465 9,937,000            
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY                  
Net income         (6,619,139)       (6,619,139)
Foreign currency translation adjustments           175,320     175,320
Share-based compensation expenses       2,365,257         2,365,257
Cash settlement on vested share options and RSU's       (823,226)         (823,226)
Repurchase of ordinary shares     $ (5,871,945)           (5,871,945)
Repurchase of ordinary shares (in shares)     47,099,300            
Exercise of share options $ 78     235,821         235,899
Exercise of share options (in shares) 7,760,550                
Issuance of ordinary shares upon vesting of restricted shares $ 29     (29)          
Issuance of ordinary shares upon vesting of restricted shares (in shares) 2,878,650                
Ending balance at Jun. 30, 2020 $ 28,907 $ 2,462 $ (6,935,492) 196,749,650 (160,217,485) (1,257,513)     28,370,529
Ending balance (in shares) at Jun. 30, 2020 2,890,695,532 246,224,465 57,036,300            
Beginning balance at Dec. 31, 2019 $ 28,800 $ 2,462 $ (1,063,547) 194,971,827 (153,598,346) (1,432,833)     38,908,363
Beginning balance (in shares) at Dec. 31, 2019 2,880,056,332 246,224,465 9,937,000            
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY                  
Net income                 (47,400,000)
Ending balance at Dec. 31, 2020 $ 28,456 $ 2,462 $ (4,672,334) 193,918,852 (200,965,075) (2,114,916)     (13,802,555)
Ending balance (in shares) at Dec. 31, 2020 2,845,646,241 246,224,465 44,511,050       2,801,135,191 246,224,465  
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY                  
Net income         (12,134,310)       (12,134,310)
Foreign currency translation adjustments           256,277     256,277
Share-based compensation expenses       2,145,240         2,145,240
Repurchase of ordinary shares     $ (1,322,195)           (1,322,195)
Repurchase of ordinary shares (in shares)     24,237,100            
Conversion of convertible notes $ 2,430     11,860,953         11,863,383
Conversion of convertible notes (in shares) 243,011,300                
Beneficial conversion feature on convertible notes       (1,368,866)         (1,368,866)
Commitment fee paid to holders of convertible notes through issuance of treasury shares (see Note 8)     $ 765,397 (436,247)         329,150
Commitment fee paid to holders of convertible notes through issuance of treasury shares (see Note 8) (in shares)     (5,500,000)            
Exercise of share options $ 20     38,833         38,853
Exercise of share options (in shares) 1,970,650                
Issuance of ordinary shares upon vesting of restricted shares $ 19     (19)          
Issuance of ordinary shares upon vesting of restricted shares (in shares) 1,873,200                
Ending balance at Jun. 30, 2021 $ 30,925 $ 2,462 $ (5,229,132) $ 206,158,746 $ (213,099,385) $ (1,858,639)     $ (13,995,023)
Ending balance (in shares) at Jun. 30, 2021 3,092,501,391 246,224,465 63,248,150       3,029,253,241 246,224,465